![[CASE STUDY] Safety and suitability of an infant formula in healthy term infants](https://www.biofortis.fr/wp-content/uploads/2023/05/12-940x675.png)
by Administrateur Biofortis | May 15, 2023 | Case studies_Clinical
Case study in Clinical trials Safety and suitability of an infant formula in healthy term infants See all the case studiesGet in touch Key information Main study endpoints Safety: growth parameters, adverse events Population 360 babies Tested product Infant...
![[CASE STUDY] Microbiome Neutral](https://www.biofortis.fr/wp-content/uploads/2023/05/Microbiome-neutral-940x675.png)
by Administrateur Biofortis | May 12, 2023 | Case studies_Biometrics & Data Science
Case study in data science Human clinical trial assessing the efficacy of a study product on osteoporosis related endpoints and associated parameters. See all the case studiesGet in touch Key information Objective The initial objective was to assess if the study...
![[CASE STUDY] Evaluation of the efficacy of a symbiotic infant formula on the incidence of gastroenterological infectious diseases during the first year of life](https://www.biofortis.fr/wp-content/uploads/2023/04/11-940x675.png)
by Administrateur Biofortis | May 11, 2023 | Case studies_Clinical
Case study in Clinical trials Evaluation of the efficacy of a synbiotic infant formula on the incidence of gastrointestinal infectious diseases during the first year of life See all the case studiesGet in touch Key information Main study endpoints – Reduction in...
![[ARTICLE] – How is microbiota involved in childhood mental illnesses such as ADHD and ASD?](https://www.biofortis.fr/wp-content/uploads/2023/04/Article-TDAH-TSA-Microbiota-1080x675.png)
by Administrateur Biofortis | Apr 7, 2023 | Health, Microbiome
There is growing evidence that the gut and the brain are linked. First observation: mental illnesses are commonly associated with gastrointestinal disorders, patients with neurological diseases often experience constipation, abdominal pain, or diarrhoea. Second: the...
![[EVENT] Biofortis will be present at Outsourcing In Clinical Trials Europe 2023](https://www.biofortis.fr/wp-content/uploads/2023/04/Post-SM_OCT-2023-1.png)
by Administrateur Biofortis | Apr 5, 2023 | News
May 3rd and 4th, 2023 in Barcelona, Spain Come and meet us at the Outsourcing In Clinical Trials (OCT) Europe 2023 in Barcelona; Spain. This event will provide participants with practical take-away messages and solutions to their most encountered operational and...
